Flow cytometry leader schedules presentations at three major healthcare investment conferences Cytek Biosciences announced its participation in three prominent investor conferences: the UBS Precision Medicine
Sector-wide fundraising activity reflects continued capital needs across biotech industry August 12 marked a particularly active day for biotech fundraising, with companies including 180 Life
Indian pharmaceutical company achieves peak performance amid ongoing financial pressures Windlas Biotech reported record Q2 net sales of approximately ₹210 crore (~$25 million USD) and
Revolutionary needle-free epinephrine achieves $15.7M quarterly revenue with accelerating market adoption ARS Pharmaceuticals delivered exceptional Q2 2025 results with $15.7 million in total revenue, including
Senior credit facility supports Afrezza pediatric launch, commercial expansion, and pipeline advancement MannKind Corporation secured up to $500 million in a senior credit facility from
Inflammatory disease biotech pursues unprecedented combination of drug development and Ethereum treasury management In an unusual move for biotechnology, 180 Life Sciences announced a massive
Inflammatory disease biotech pursues unprecedented combination of drug development and Ethereum treasury management In an unusual move for biotechnology, 180 Life Sciences announced a massive
Series B funding supports programmable mRNA platform with lead candidate showing promise in solid tumors Massachusetts-based Strand Therapeutics completed a $153 million Series B financing
Pfizer and BioNTech have reached a substantial $740 million settlement agreement with CureVac to resolve a complex patent dispute involving foundational mRNA technology that underpins
The digital health sector is experiencing a notable resurgence, with U.S. startups raising $6.4 billion in the first half of 2025, marking a modest but
